Cannabielsoin
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||
General | |||||||||||||
Surname | Cannabielsoin | ||||||||||||
other names |
|
||||||||||||
Molecular formula | C 21 H 30 O 3 | ||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
Drug information | |||||||||||||
Drug class | |||||||||||||
properties | |||||||||||||
Molar mass | 330.46 g mol −1 | ||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Cannabielsoin ( CBE ) is a cannabinoid first observed in 1983 by researchers at Ohio State University while studying the metabolism of cannabidiol , the metabolite of which it is. Cannabielsoin was then studied for its biological formation at the University of Hokuriku in Japan .
In suspension cultures of Cannabis sativa and Saccharum officinarum , cannabielsoin is present under normal growth conditions. It could also be detected in the liver of guinea pigs to which cannabidiol had been administered intraperitoneally an hour earlier . The compound shows little effect on body temperature and pentobarbital-induced sleep.
A total of five different cannabinoids in this group are known to date.
Individual evidence
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ^ A b I. Yamamoto, H. Gohda, S. Narimatsu, H. Yoshimura: Identification of cannabielsoin, a new metabolite of cannabidiol formed by guinea-pig hepatic microsomal enzymes, and its pharmacological activity in mice. In: J Pharmacobiodyn. December 1988, PMID 3254981 .
- ↑ Roger Pertwee: Handbook of Cannabis . OUP Oxford, 2014, ISBN 978-0-19-163969-2 , pp. 11 ( limited preview in Google Book search).